Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-18 Sale |
2021-06-22 4:44 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
48,493 | $60.11 | $2,914,851 | 16,479 (Direct) |
View |
2021-06-17 Sale |
2021-06-21 4:18 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
2,502 | $60.02 | $150,170 | 17,372 (Direct) |
View |
2021-06-09 Sale |
2021-06-11 5:00 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
28,002 | $60.09 | $1,682,554 | 45,114 (Direct) |
View |
2021-06-07 Sale |
2021-06-09 4:06 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
10,943 | $60.05 | $657,171 | 86,940 (Direct) |
View |
2021-04-19 Sale |
2021-04-21 5:11 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
17,611 | $55.12 | $970,636 | 71,332 (Direct) |
View |
2020-05-20 Sale |
2020-05-21 5:05 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
3,583 | $50.01 | $179,200 | 24,029 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-09-12 9:11 pm |
N/A 2034-08-06 |
Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director |
0 | $0 | 59,501 (Direct) |
View |
2022-06-22 Option Award |
2022-06-24 4:31 pm |
N/A 2032-06-21 |
Alaunos Therapeutics Inc. | TCRT | Bowden Christopher Director |
140,000 | $0 | 144,167 (Direct) |
View |
2021-06-18 Exercise |
2021-06-22 4:44 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
46,608 | $50.4 | 16,479 (Direct) |
View |
2021-06-18 Exercise |
2021-06-22 4:44 pm |
N/A 2026-02-15 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
48,493 | $0 | 16,479 (Direct) |
View |
2021-06-18 Exercise |
2021-06-22 4:44 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
1,885 | $39.76 | 16,479 (Direct) |
View |
2021-06-17 Exercise |
2021-06-21 4:18 pm |
N/A 2026-02-15 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
2,502 | $0 | 17,372 (Direct) |
View |
2021-06-17 Exercise |
2021-06-21 4:18 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
2,502 | $39.76 | 17,372 (Direct) |
View |
2021-06-09 Exercise |
2021-06-11 5:00 pm |
N/A 2026-02-15 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
28,002 | $0 | 45,114 (Direct) |
View |
2021-06-09 Exercise |
2021-06-11 5:00 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
28,002 | $39.76 | 45,114 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:06 pm |
N/A 2026-02-15 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
10,943 | $0 | 86,940 (Direct) |
View |
2021-06-07 Exercise |
2021-06-09 4:06 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
10,943 | $39.76 | 86,940 (Direct) |
View |
2021-03-04 Option Award |
2021-05-06 7:20 pm |
N/A 2031-03-03 |
ZIOPHARM ONCOLOGY INC | ZIOP | Bowden Christopher Director |
35,417 | $0 | 35,417 (Direct) |
View |
2021-04-19 Exercise |
2021-04-21 5:11 pm |
N/A 2024-05-30 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
17,611 | $0 | 71,332 (Direct) |
View |
2021-04-20 Exercise |
2021-04-21 5:11 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
1,888 | $39.76 | 71,332 (Direct) |
View |
2021-04-19 Exercise |
2021-04-21 5:11 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
15,723 | $35.16 | 71,332 (Direct) |
View |
2021-02-24 Tax Withholding |
2021-02-24 4:11 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
986 | $0 | 18,743 (Direct) |
View |
2021-02-22 Exercise |
2021-02-24 4:11 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
3,334 | $0 | 18,743 (Direct) |
View |
2021-02-16 Tax Withholding |
2021-02-17 4:14 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
2,069 | $0 | 21,062 (Direct) |
View |
2021-02-14 Exercise |
2021-02-17 4:14 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
6,750 | $0 | 21,062 (Direct) |
View |
2021-02-10 Option Award |
2021-02-12 4:22 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
55,000 | $0 | 55,000 (Direct) |
View |
2020-05-21 Option Award |
2020-05-22 5:09 pm |
N/A 2030-05-20 |
MIRAGEN THERAPEUTICS INC. | MGEN | Bowden Christopher Director |
24,000 | $0 | 24,000 (Direct) |
View |
2020-05-20 Exercise |
2020-05-21 5:05 pm |
N/A 2024-05-30 |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
3,583 | $0 | 24,029 (Direct) |
View |
2020-05-20 Exercise |
2020-05-21 5:05 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer |
3,583 | $35.16 | 24,029 (Direct) |
View |